The relationship between catechol-O-methyltransferase (COMT) polymorphisms and the development of breast cancer

Chinese Journal of Clinical Oncology

Volumn 34, Issue 8, 2007, Pages 430-433

  Fan, Yu ^a   Feng, Yumei ^a   Wang, Limei ^a   Wang, Ying ^a   Fu, Li ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast; Cancer; COMT; Development; Genetic; Polymorphisms; Prognosis

Indexed keywords

EID: 84865055030     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kristensen VN, Borresen-Dale AL. Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism [J]. Mutat Res, 2000, 462(2-3): 323-333
2. Dawling S, Roodi N, Mernaugh RL, et al. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms [J]. Cancer Res, 2001, 61(18): 6716-6722
3. Shield AJ, Thomae BA, Eckloff BW, et al. Human catechol Omethyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes [J]. Mol Psychiatry, 2004, 9(2): 151-160
4. Lavigne JA, Helzlsouer KJ, Huang HY, et al. An association between the allele coding for a low activity variant of catechol-Omethyltransferase and the risk for breast cancer [J]. Cancer Res, 1997, 57(24): 5493-5497
5. Gallicchio L, Berndt SI, McSorley MA, et al. Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease [J]. BMC Cancer, 2006, 6(1): 173-183
6. Yager JD. Endogenous estrogens as carcinogens through metabolic activation [J]. J Natl Cancer Inst Monogr, 2000, (27): 67-73
7. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives [J]. Carcinogenesis, 1998, 19(1): 1-27
8. Service RF. New role for estrogen in cancer [J]? Science, 1998, 279(5357): 1631-1633
9. Akanni A, Abul-Hajj YJ. Estrogen-nucleic acid adducts: reaction of 3,4-estrone-O-quinone radical anion with deoxyribonucleosides [J]. Chem Res Toxicol, 1997, 10(7): 760-766
10. Cavalieri EL, Stack DE, Devanesan PD, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators [J]. Proc Natl Acad Sci U S A, 1997, 94(20): 10937-10942
11. Westerlind KC, Gibson KJ, Evans GL, et al. The catechol estrogen, 4-hydroxyestrone, has tissue-specific estrogen actions [J]. J Endocrinol, 2000, 167(2): 281-287
12. Schutze N, Vollmer G, Tiemann I, et al. Catecholestrogens are MCF-7 cell estrogen receptor agonists [J]. J Steroid Biochem Mol Biol, 1993, 46(6): 781-789
13. Rivera-Calimlim L, Reilly DK. Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance [J]. Clin Pharmacol Ther, 1984, 35(6): 804-809
14. Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism [J]. Mutat Res, 2003, 544(1): 9-41
15. Sidor C, D'Amato R, Miller KD. The potential and suitability of 2-methoxyestradiol in cancer therapy [J]. Clin Cancer Res, 2005, 11(16): 6094-6095
16. Kamath K, Okouneva T, Larson G, et al. 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules [J]. Mol Cancer Ther, 2006, 5(9): 2225-2233
17. Miyoshi Y, Noguchi S. Polymorphisms of estrogen synthesizing and metabolizing genes and breast cancer risk in Japanese women [J]. Biomed Pharmacother, 2003, 57(10): 471-481
18. Matsui A, Ikeda T, Enomoto K, et al. Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase [J]. Cancer Lett, 2000, 150(1): 23-31